II International Congress of Georgian Association of Oncological Urology – 2018

Georgian Association of Oncological Urology has planned to hold a congress of unprecedented scale on 26-27th October, 2018. Participators of the event are among the top one specialist-experts from all over the world. Outstanding scientists and doctors from USA, Germany, Sweden, France, Italy, Belgium, UK, Russia, Ukraine, Armenia, Azerbaijan and Georgia will perform the congress. (see: The Program).

The meeting is supported by professional associations of the field and the heads of the associations of the leading western countries and countries of the region, given below:

  • Society of Urologic Oncology
  • European Association of Urology (EAU)
  • World Urologic Oncology Association
  • European Society for Medical Oncology (ESMO)
  • Russian Association of Oncological Urology
  • Ukrainian Oncourological Society
  • Azerbaijan Urologists Association
  • Armenian Association of Urology

Organizing Committee of 2018 Congress

Proposed sponsorship deals

Tags:
Karazanashvili Guram  Burkadze George  
Characteristics and clinical significance of histological variants of bladder cancer
President at Georgian Association of Oncological Urology, MD, Professor
University Clinic, Head of Pathology Department, Professor
Brausi Maurizio  
Bladder Cancer prevention program
Chairman of European Section of Oncological Urology. Ex. President Italian Society of Urology
Brausi Maurizio  
Diagnosis and treatment of T1 high Grade TCC of the bladder : what has changed in the last years
Chairman of European Section of Oncological Urology. Ex. President Italian Society of Urology
Brausi Maurizio  
Bladder sparing in muscle invasive bladder cancer: facts of fiction?
Chairman of European Section of Oncological Urology. Ex. President Italian Society of Urology
Necchi Andrea  
Immunotherapy in early and advanced stages of bladder cancer
European Society of Medical Oncology, Faculty Group in Genitourinary cancers
Necchi Andrea  
Latest data on genomics of urothelial cancer
European Society of Medical Oncology, Faculty Group in Genitourinary cancers
Necchi Andrea  
Implications for targeted therapy of bladder cancer
European Society of Medical Oncology, Faculty Group in Genitourinary cancers
Karazanashvili Guram  
Best Georgian Publication 2018
President at Georgian Association of Oncological Urology, MD, Professor
Schmidinger Manuela  
Treatment of metastatic RCC in 2018
Program Director for Renal cell carcinoma, Vienna Medical University
Stefan Müller  
Problems and pitfalls of minimal invasive or organ preserving therapy in kidney and bladder cancer
Director, Department of Urology, University of Bonn.
Matveev Vsevold  
Surgical approaches to advanced kidney tumours
President, Russian Association of Oncologic Urology
Stakhovsky Oleksandr  
Neoadjuvant therapy in the treatment of renal cell carcinoma.

Voilenko O

Department of Oncourology, Ukrainian Cancer Center
Stakhovsky Oleksandr  
Quality of life after modified ureterocutaneostomy
Department of Oncourology, Ukrainian Cancer Center
Stakhovsky Eduard  
Assessment of the complexity kidney tumor

Speakers: Pikul M, Stakhovsky Eduard

President, Ukrainian Association of Oncological Urology
Stakhovsky Eduard  
Partial nephrectomy for upper tract urothelial carcinoma

Speakers: Pikul M, Stakhovsky Eduard

President, Ukrainian Association of Oncological Urology
Sergey Polyakov  
Fluorescent cystoscopy-assisted TUR: does it affect outcome in NMIBC patients?
Chief, Department of Urology Belarusian Cancer Center
Fuad Guliev  
Laparoscopic nephrectomy: our experience
Chief, Department of Urology and Deputy Director of National Oncology Center of Azerbaijan
Melkonyan Nairi  Varuzhan H.Shahsuvaryan  
Renal Cell Carcinoma: Embolizaton, Cytoreductve nephrectomy, Targeted therapies

Speakers: Shahsuvaryan Varujan, Melkonyan Nairi

MD, Urologist, National Center of Oncology
Head, Department of Oncourology, National Center of Oncology, Armenia
Vladislav Bargman  
Surgical approaches to adrenal malignancies
MD, Chief of Service, Division of Urology, Department of Surgery, University Hospital Newark, NJ
Frank Kahmann  
Prostate Seed Brachytherapy - Present and Future
MD, Urologist; specialty: LDR-brachytherapy, Meoclinic, Berlin
Mirzagaleb Tillyashaykhov  
Exentaration in locally advanced cervical cancer patients
National Cancer Center of Uzbekistan; Director and Lead of Oncourology department
Kokaia Zaal  
Prostate cancer stem cells - current status and future challenges
PhD, Professor, Director of Stem Cell Center, Lund University, Sweden
Evans Christopher  
Genomics and Biomarkers in Prostate Cancer
President, Society Urologic Oncology of USA. Professor and Chairman, Department of Urology
Evans Christopher  
Lymphadenectomy in Prostate Cancer: Yes, No, Maybe?
President, Society Urologic Oncology of USA. Professor and Chairman, Department of Urology
Evans Christopher  
Prostate cancer screening and the impact of screening recommendations
President, Society Urologic Oncology of USA. Professor and Chairman, Department of Urology
Evans Christopher  
Targeting Androgen Receptor Signaling in Prostate Cancer
President, Society Urologic Oncology of USA. Professor and Chairman, Department of Urology
Bossi Alberto  
RT and ADT for locally advanced PCa: what's new?
Head of the Urology and Prostate Brachytherapy Unit at the Gustave Roussy Cancer Institute
Bossi Alberto  
Post-prostaectomy RT: adjuvant or (early-) salvage?
Head of the Urology and Prostate Brachytherapy Unit at the Gustave Roussy Cancer Institute
Bossi Alberto  
Any role for (local) RT in the up-front PCa metastatic patient?
Head of the Urology and Prostate Brachytherapy Unit at the Gustave Roussy Cancer Institute
De Santis Maria  
Is there a role for immunotherapy of prostate cancer?
Chair of Section for Interdisciplinary Genitourinary Cancer Medicine at the Charité Medical University Hospital, Berlin, Germany
De Santis Maria  
Treatment of advanced and metastatic prostate cancer - the more, the earlier, the better?
Chair of Section for Interdisciplinary Genitourinary Cancer Medicine at the Charité Medical University Hospital, Berlin, Germany
Van Poppel  
High risk Prostate Cancer: Surgery first?
Adjunct Secretary General of European Association of Urology, Faculty Member of the Europe
Abrahamsson Per-Anders  
Epidemiology and Risk Factors for Prostate Cancer
Professor, University of Lund.
Abrahamsson Per-Anders  
Role of GnRH Agonist vs. Antagonist vs. Orchiectomy in Management of Prostate Cancer
Professor, University of Lund.
Abrahamsson Per-Anders  
Prostate cancer screening in Europe: The arguments for
Professor, University of Lund.
Karazanashvili Guram  
Natural History of high risk and very high risk prostate cancer after radical surgery - own experience
President at Georgian Association of Oncological Urology, MD, Professor
Matveev Vsevold  
Cytoreductive prostatectomy in patients with metastatic prostate cancer
President, Russian Association of Oncologic Urology
Ahlgren Goran  
Docetaxel after surgery, radiation therapy or biochemical progression - is there a benefit?
Associate Professor of Urology and Senior Consultant in Urology at Skane University Hospital, Sweden
George Bochorishvili  
Peculiarities of active surveillance in patients with PC in Georgia
President, Georgian Men's Health Association
Andro Dzneladze  George Bochorishvili  
Selection of patients with prostate cancer for low dose brachitherapy
Radiologist, Doctor of Medicine
President, Georgian Men's Health Association
Alekseev Boris  
Intraoperative detection of micrometastases in sentinel lymph nodes during radical prostatectomy
Deputy Director for Science in National Medical Research Center of Radiology in Moscow
Alekseev Boris  
Neoajuvant and adjuvant chemo-hormonal therapy in prostate cancer patients with lymph node's metastases: the results of prospective study
Deputy Director for Science in National Medical Research Center of Radiology in Moscow
Mirzagaleb Tillyashaykhov

Mirzagaleb Tillyashaykhov

National Cancer Center of Uzbekistan; Director and Lead of Oncourology department
Frank Kahmann

Frank Kahmann

MD, Urologist; specialty: LDR-brachytherapy, Meoclinic, Berlin
Vladislav Bargman

Vladislav Bargman

MD, Chief of Service, Division of Urology, Department of Surgery, University Hospital Newark, NJ
Andro Dzneladze

Andro Dzneladze

Radiologist, Doctor of Medicine
Karazanashvili Guram

Karazanashvili Guram

President at Georgian Association of Oncological Urology, MD, Professor
Burkadze George

Burkadze George

University Clinic, Head of Pathology Department, Professor
Stefan Müller

Stefan Müller

Director, Department of Urology, University of Bonn.
George Bochorishvili

George Bochorishvili

President, Georgian Men's Health Association
Kokaia Zaal

Kokaia Zaal

PhD, Professor, Director of Stem Cell Center, Lund University, Sweden
Fuad Guliev

Fuad Guliev

Chief, Department of Urology and Deputy Director of National Oncology Center of Azerbaijan
Varuzhan H.Shahsuvaryan

Varuzhan H.Shahsuvaryan

Head, Department of Oncourology, National Center of Oncology, Armenia
Stakhovsky Oleksandr

Stakhovsky Oleksandr

Department of Oncourology, Ukrainian Cancer Center
Stakhovsky Eduard

Stakhovsky Eduard

President, Ukrainian Association of Oncological Urology
Alekseev Boris

Alekseev Boris

Deputy Director for Science in National Medical Research Center of Radiology in Moscow
Melkonyan Nairi

Melkonyan Nairi

MD, Urologist, National Center of Oncology
Sergey Polyakov

Sergey Polyakov

Chief, Department of Urology Belarusian Cancer Center
Bossi Alberto

Bossi Alberto

Head of the Urology and Prostate Brachytherapy Unit at the Gustave Roussy Cancer Institute
Abrahamsson Per-Anders

Abrahamsson Per-Anders

Professor, University of Lund.
Ahlgren Goran

Ahlgren Goran

Associate Professor of Urology and Senior Consultant in Urology at Skane University Hospital, Sweden
Matveev Vsevold

Matveev Vsevold

President, Russian Association of Oncologic Urology
Schmidinger Manuela

Schmidinger Manuela

Program Director for Renal cell carcinoma, Vienna Medical University
De Santis Maria

De Santis Maria

Chair of Section for Interdisciplinary Genitourinary Cancer Medicine at the Charité Medical University Hospital, Berlin, Germany
Necchi Andrea

Necchi Andrea

European Society of Medical Oncology, Faculty Group in Genitourinary cancers
Brausi Maurizio

Brausi Maurizio

Chairman of European Section of Oncological Urology. Ex. President Italian Society of Urology
Van Poppel

Van Poppel

Adjunct Secretary General of European Association of Urology, Faculty Member of the Europe
Evans Christopher

Evans Christopher

President, Society Urologic Oncology of USA. Professor and Chairman, Department of Urology
Book Hotel:
Gala dinner:
Transportation from the airport:

Event Details

October 26, 2018 09:00
October 27, 2018 19:00
Assembly hall

Sponsors